{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T23:12:35Z","timestamp":1792019555476,"version":"4.4.0"},"reference-count":125,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Physical and Rehabilitation Medicine"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.rehab.2015.10.003","type":"journal-article","created":{"date-parts":[[2016,1,18]],"date-time":"2016-01-18T16:49:19Z","timestamp":1453135759000},"page":"42-57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":110,"title":["Drugs for behavior disorders after traumatic brain injury: Systematic review and expert consensus leading to French recommendations for good practice"],"prefix":"10.1016","volume":"59","author":[{"given":"D.","family":"Plantier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Luaut\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rehab.2015.10.003_bib0005","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1176\/ajp.152.10.1493","article-title":"Psychiatric disorders and functional disability in outpatients with traumatic brain injuries","volume":"152","author":"Fann","year":"1995","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.rehab.2015.10.003_bib0010","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1037\/0022-006X.60.3.360","article-title":"Personality disturbances associated with traumatic brain injury","volume":"60","author":"Prigatano","year":"1992","journal-title":"J Consult Clin Psychol"},{"key":"10.1016\/j.rehab.2015.10.003_bib0015","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1001\/jama.2015.3656","article-title":"Preferred Reporting Items for Systematic Review and Meta-Analyses of individual participant data: the PRISMA-IPD Statement","volume":"28","author":"Stewart","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.rehab.2015.10.003_bib0020","first-page":"917","article-title":"The treatment of agitation during initial hospitalization after traumatic brain injury","volume":"73","author":"Brooke","year":"1992","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.rehab.2015.10.003_bib0025","first-page":"105","article-title":"Effect of pindolol administration on serum levels of thioridazine, haloperidol, phenytoin, and phenobarbital","volume":"49","author":"Greendyke","year":"1988","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.rehab.2015.10.003_bib0030","first-page":"423","article-title":"Therapeutic effects of pindolol on behavioral disturbances associated with organic brain disease: a double-blind study","volume":"47","author":"Greendyke","year":"1986","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.rehab.2015.10.003_bib0035","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/00005053-198605000-00005","article-title":"Propranolol treatment of assaultive patients with organic brain disease. A double-blind crossover, placebo-controlled study","volume":"174","author":"Greendyke","year":"1986","journal-title":"J Nerv Ment Dis"},{"key":"10.1016\/j.rehab.2015.10.003_bib0040","first-page":"279","article-title":"Treatment of agitation following traumatic brain injury: a review of the literature","volume":"20","author":"Levy","year":"2005","journal-title":"Neuro Rehabil"},{"key":"10.1016\/j.rehab.2015.10.003_bib0045","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/01.phm.0000179438.22235.08","article-title":"Agitation after traumatic brain injury: considerations and treatment options","volume":"84","author":"Lombard","year":"2005","journal-title":"Am J Phys Med Rehabil"},{"key":"10.1016\/j.rehab.2015.10.003_bib0050","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1176\/ajp.142.9.1108","article-title":"Metoprolol for intermittent explosive disorder","volume":"142","author":"Mattes","year":"1985","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.rehab.2015.10.003_bib0055","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S0003-9993(97)90051-4","article-title":"Measurement and treatment of agitation following traumatic brain injury: II. A survey of the Brain Injury Special Interest Group of the American Academy of Physical Medicine and Rehabilitation","volume":"78","author":"Fugate","year":"1997","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.rehab.2015.10.003_bib0060","first-page":"1","article-title":"Pharmacological management for agitation and aggression in people with acquired brain injury","volume":"18","author":"Fleminger","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.rehab.2015.10.003_bib0065","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1089\/neu.2006.23.1468","article-title":"Neurobehavioral Guidelines Working Group. Guidelines for the pharmacologic treatment of neurobehavioral sequelae of traumatic brain injury","volume":"23","author":"Warden","year":"2006","journal-title":"J Neurotrauma"},{"key":"10.1016\/j.rehab.2015.10.003_bib0070","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1682\/JRRD.2008.09.0120","article-title":"Pharmacological management of neurobehavioral disorders following traumatic brain injury\u00a0\u2013\u00a0A state-of-the-art review","volume":"46","author":"Chew","year":"2009","journal-title":"Rehabil Res Dev Serv"},{"key":"10.1016\/j.rehab.2015.10.003_bib0075","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.pmrj.2008.10.013","article-title":"Managing agitation associated with traumatic brain injury: behavioral versus pharmacologic interventions?","volume":"1","author":"Flanagan","year":"2009","journal-title":"PM&R"},{"key":"10.1016\/j.rehab.2015.10.003_bib0080","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1017\/S0265021507003316","article-title":"Pharmacological treatment of neurobehavioural sequelae of traumatic brain injury","volume":"25","author":"Lombardi","year":"2008","journal-title":"Eur J Anaesthesiol"},{"key":"10.1016\/j.rehab.2015.10.003_bib0085","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/026990501458399","article-title":"Methotrimeprazine in the treatment of agitation in acquired brain injury patients","volume":"15","author":"Maryniak","year":"2001","journal-title":"Brain Inj"},{"key":"10.1016\/j.rehab.2015.10.003_bib0090","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0168-6054(02)00353-7","article-title":"Pharmacological treatment of post-traumatic behavioural disorders","volume":"46","author":"Richard","year":"2003","journal-title":"Ann Readapt Med Phys"},{"key":"10.1016\/j.rehab.2015.10.003_bib0095","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.rehab.2011.04.003","article-title":"Aggressive behaviour after traumatic brain injury","volume":"54","author":"Sao\u00fbt","year":"2011","journal-title":"An Phys Rehabil Med"},{"key":"10.1016\/j.rehab.2015.10.003_bib0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2788.2009.01232.x","article-title":"Pharmacotherapy for aggressive behaviours in persons with intellectual disabilities: treatment or mistreatment?","volume":"54","author":"Tsiouris","year":"2010","journal-title":"J Intellect Disabil Res"},{"key":"10.1016\/j.rehab.2015.10.003_bib0105","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1080\/02699050701559558","article-title":"Pharmacological management of neurobehavioural sequelae of traumatic brain injury: a survey of current physiatric practice","volume":"21","author":"Francisco","year":"2007","journal-title":"Brain Inj"},{"key":"10.1016\/j.rehab.2015.10.003_bib0110","first-page":"954","article-title":"Neuroleptic malignant syndrome in traumatic brain injury patients treated with haloperidol","volume":"66","author":"Bellamy","year":"2009","journal-title":"J Trauma"},{"key":"10.1016\/j.rehab.2015.10.003_bib0115","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1017\/S0265021507003250","article-title":"Long term psychiatric disorders after traumatic brain injury","volume":"25","author":"Fleminger","year":"2008","journal-title":"Eur J Anaesthesiol"},{"key":"10.1016\/j.rehab.2015.10.003_bib0120","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1080\/0269905031000070224","article-title":"Early recognition of neuroleptic malignant syndrome during traumatic brain injury rehabilitation","volume":"17","author":"Kadyan","year":"2003","journal-title":"Brain inj"},{"key":"10.1016\/j.rehab.2015.10.003_bib0125","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/09540260310001606746","article-title":"Pharmacological management of the psychiatric aspects of traumatic brain injury","volume":"15","author":"Lee","year":"2003","journal-title":"Int Rev Psychiatry"},{"key":"10.1016\/j.rehab.2015.10.003_bib0130","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4103\/1793-5482.92173","article-title":"Neuroleptic malignant syndrome and closed head injury: a case report and review","volume":"6","author":"Shaikh","year":"2011","journal-title":"Asian J Neurosurg"},{"key":"10.1016\/j.rehab.2015.10.003_bib0135","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/BF01708104","article-title":"Neuroleptic malignant syndrome in a patient with head injury","volume":"22","author":"Perez-Vela","year":"1996","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.rehab.2015.10.003_bib0140","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1080\/026990599121034","article-title":"Neuroleptic malignant syndrome induced by haloperidol following traumatic brain injury","volume":"13","author":"Wilkinson","year":"1999","journal-title":"Brain Inj"},{"key":"10.1016\/j.rehab.2015.10.003_bib0145","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1126\/science.7100929","article-title":"Amphetamine, haloperidol, and experience interact to affect rate of recovery after motor cortex injury","volume":"27","author":"Feeney","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.rehab.2015.10.003_bib0150","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1097\/01.PHM.0000091982.33232.CB","article-title":"Haloperidol, but not olanzapine, impairs cognitive performance after traumatic brain injury in rats","volume":"82","author":"Wilson","year":"2003","journal-title":"Am J Phys Med Rehabil"},{"key":"10.1016\/j.rehab.2015.10.003_bib0155","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1097\/01.CCM.0000256722.88854.C0","article-title":"Differential effects of single versus multiple administrations of haloperidol and resperidone on functionnal outcome after experimental brain trauma","volume":"35","author":"Kline","year":"2007","journal-title":"Crit Care Med"},{"key":"10.1016\/j.rehab.2015.10.003_bib0160","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.neulet.2008.10.076","article-title":"Chronic administration of antipsychotics impede behavioral recovery after experimental traumatic brain injury","volume":"448","author":"Kline","year":"2008","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.rehab.2015.10.003_bib0165","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.lfs.2008.08.007","article-title":"Administration of haloperidol and risperidone after neurobehavioral testing hinderst he recovery of traumatic brain injury-induced deficits","volume":"83","author":"Hoffman","year":"2008","journal-title":"Life Sci"},{"key":"10.1016\/j.rehab.2015.10.003_bib0170","first-page":"30","article-title":"Agitation in closed head injury: haloperidol effects on rehabilitation outcome","volume":"66","author":"Rao","year":"1985","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.rehab.2015.10.003_bib0175","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/026990597123494","article-title":"Cognitive effects of antipsychotic agents in persons with traumatic brain injury","volume":"11","author":"Stanislav","year":"1997","journal-title":"Brain inj"},{"key":"10.1016\/j.rehab.2015.10.003_bib0180","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/01.jcp.0000222513.63767.de","article-title":"A randomized, 1-year follow-up study of olanzapine and risperidone in the treatment of negative symptoms in outpatients with schizophrenia","volume":"26","author":"Alvarez","year":"2006","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.rehab.2015.10.003_bib0185","doi-asserted-by":"crossref","first-page":"391","DOI":"10.4088\/JCP.v63n0503","article-title":"Olanzapine in the treatment of apathy in previously depressed participants maintained with selective serotonin reuptake inhibitors: an open-label, flexible-dose study","volume":"63","author":"Marangell","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.rehab.2015.10.003_bib0190","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1017\/S1041610200006633","article-title":"Risperidone in the treatment of patients with Alzheimer's disease with negative symptoms","volume":"12","author":"Negr\u00f3n","year":"2000","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.rehab.2015.10.003_bib0195","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1176\/appi.psy.48.3.217","article-title":"Apathy syndrome after traumatic brain injury compared with deficits in schizophrenia","volume":"48","author":"Rao","year":"2007","journal-title":"Psychosomatics"},{"key":"10.1016\/j.rehab.2015.10.003_bib0200","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s11940-007-0022-5","article-title":"Apathy and its treatment","volume":"9","author":"Roth","year":"2007","journal-title":"Curr Treat Options Neurol"},{"key":"10.1016\/j.rehab.2015.10.003_bib0205","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/HTR.0b013e3181be1eab","article-title":"Sudden cardiac death and stroke with the use of antipsychotic medications: implications for clinicians treating individuals with traumatic brain injury","volume":"25","author":"Glenn","year":"2010","journal-title":"J Head Trauma Rehabil"},{"key":"10.1016\/j.rehab.2015.10.003_bib0210","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1197\/j.aem.2005.12.007","article-title":"Droperidol use in the emergency department is not safe","volume":"13","author":"Prosser","year":"2006","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.rehab.2015.10.003_bib0215","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/026990500120736","article-title":"Evaluating the usage of droperidol in acutely agitated persons with brain injury","volume":"14","author":"Stanislav","year":"2000","journal-title":"Brain Inj"},{"key":"10.1016\/j.rehab.2015.10.003_bib0220","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1023\/B:PSAQ.0000031791.53142.85","article-title":"New treatments for agitation","volume":"75","author":"Citrome","year":"2004","journal-title":"Psychiatr Q"},{"key":"10.1016\/j.rehab.2015.10.003_bib0225","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.2165\/11596930-000000000-00000","article-title":"Pharmacological management of acute and persistent aggression in forensic psychiatry settings","volume":"25","author":"Citrome","year":"2011","journal-title":"CNS Drugs"},{"key":"10.1016\/j.rehab.2015.10.003_bib0230","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1155\/2007\/529076","article-title":"Efficacy of ziprasidone in controlling agitation during post-traumatic amnesia","volume":"18","author":"No\u00e9","year":"2007","journal-title":"Behav Neurol"},{"key":"10.1016\/j.rehab.2015.10.003_bib0235","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1176\/jnp.2006.18.4.547","article-title":"A pilot study of quetiapine treatment of aggression due to traumatic brain injury","volume":"18","author":"Kim","year":"2006","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.rehab.2015.10.003_bib0240","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.pnpbp.2010.09.011","article-title":"High dose quetiapine in the treatment of psychosis due to traumatic brain injury. A case report","volume":"35","author":"Tr\u00e9meau","year":"2011","journal-title":"Prog Neuro-psychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.rehab.2015.10.003_bib0245","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.pnpbp.2009.08.026","article-title":"Posttraumatic brain injury psychosis successfully treated with olanzapine","volume":"34","author":"Viana Bde","year":"2010","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.rehab.2015.10.003_bib0250","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/00004714-199306000-00008","article-title":"Clozapine response and adverse effects in nine brain-injured patients","volume":"13","author":"Michals","year":"1993","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.rehab.2015.10.003_bib0255","first-page":"3","article-title":"Olanzapine treatment in an organic hallucinosis patient (letter)","author":"Umansky","year":"2000","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.rehab.2015.10.003_bib0260","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/00001199-200511000-00006","article-title":"Treatment of depression following traumatic brain injury","volume":"20","author":"Alderfer","year":"2005","journal-title":"J Head Trauma Rehabil"},{"key":"10.1016\/j.rehab.2015.10.003_bib0265","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/0168-6054(96)86981-9","article-title":"Int\u00e9r\u00eat de la carbamaz\u00e9pine dans la prise en charge des troubles de l\u2019humeur et du comportement des traumatismes cranio-enc\u00e9phaliques graves","volume":"39","author":"Louis","year":"1996","journal-title":"Ann Readapt Med Phys"},{"key":"10.1016\/j.rehab.2015.10.003_bib0270","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00002060-198802000-00006","article-title":"Amitriptyline for post-traumatic agitation","volume":"67","author":"Mysiw","year":"1988","journal-title":"Am J Phys Med Rehab"},{"key":"10.1016\/j.rehab.2015.10.003_bib0275","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/026990599121890","article-title":"Selective serotonin reuptake inhibitor treatment of post-traumatic Kl\u00fcver-Bucy syndrome","volume":"13","author":"Slaughter","year":"1999","journal-title":"Brain Inj"},{"key":"10.1016\/j.rehab.2015.10.003_bib0280","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/ana.22117","article-title":"Groupe de r\u00e9flexion sur l\u2019\u00e9valuation des fonctions ex\u00e9cutives Study Group. Dysexecutive syndrome: diagnostic criteria and validation study","volume":"68","author":"Godefroy","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.rehab.2015.10.003_bib0285","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1080\/026990501750111274","article-title":"Sertaline to improve arousal and alertness in severe traumatic brain injury","volume":"15","author":"Meythaler","year":"2001","journal-title":"Brain inj"},{"key":"10.1016\/j.rehab.2015.10.003_bib0290","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1080\/026990598122223","article-title":"Treatment of aggression and irritability after head injury","volume":"12","author":"Kant","year":"1998","journal-title":"Brain inj"},{"key":"10.1016\/j.rehab.2015.10.003_bib0295","first-page":"180","article-title":"Amitriptyline for agitation in head injury","volume":"66","author":"Jackson","year":"1985","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.rehab.2015.10.003_bib0300","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1080\/02699050010005931","article-title":"The use of bupropion in the treatment of restlessness after a traumatic brain injury","volume":"15","author":"Teng","year":"2001","journal-title":"Brain Inj"},{"key":"10.1016\/j.rehab.2015.10.003_bib0305","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1089\/neu.2009.1091","article-title":"Treatment for depression after traumatic brain injury: a systematic review","volume":"26","author":"Fann","year":"2009","journal-title":"J Neurotrauma"},{"key":"10.1016\/j.rehab.2015.10.003_bib0310","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.apmr.2008.11.005","article-title":"A randomized controlled trial of sertraline for the treatment of depression in persons with traumatic brain injury","volume":"90","author":"Ashman","year":"2009","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.rehab.2015.10.003_bib0315","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1176\/jnp.12.2.226","article-title":"Sertraline in the treatment of major depression following mild traumatic brain injury","volume":"12","author":"Fann","year":"2000","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.rehab.2015.10.003_bib0320","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2190\/KQ48-XT0L-2H14-5UMV","article-title":"Fluoxetine's effects on cognitive performance in patients with traumatic brain injury","volume":"32","author":"Horsfield","year":"2002","journal-title":"Int J Psychiatry Med"},{"key":"10.1016\/j.rehab.2015.10.003_bib0325","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1272\/jnms.70.313","article-title":"Therapeutic effects of milnacipran (serotonin noradrenalin reuptake inhibitor) on depression following mild and moderate traumatic brain injury","volume":"70","author":"Kanetani","year":"2003","journal-title":"J Nihon Med Sch"},{"key":"10.1016\/j.rehab.2015.10.003_bib0330","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1080\/026990599121368","article-title":"Moclobemide in the treatment of major depressive disorder (DSM-3) following traumatic brain injury","volume":"13","author":"Newburn","year":"1999","journal-title":"Brain Inj"},{"key":"10.1016\/j.rehab.2015.10.003_bib0335","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/026990501458371","article-title":"Mood and behavioural disorders following traumatic brain injury: clinical evaluation and pharmacological management","volume":"15","author":"Perino","year":"2001","journal-title":"Brain Inj"},{"key":"10.1016\/j.rehab.2015.10.003_bib0340","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1177\/0269881107083845","article-title":"An open-label study of citalopram for major depression following traumatic brain injury","volume":"22","author":"Rapoport","year":"2008","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.rehab.2015.10.003_bib0345","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.4088\/JCP.09m05086blu","article-title":"A randomized controlled trial of antidepressant continuation for major depression following traumatic brain injury","volume":"71","author":"Rapoport","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.rehab.2015.10.003_bib0350","doi-asserted-by":"crossref","first-page":"582","DOI":"10.4088\/JCP.v57n1206","article-title":"Antidepressant pharmacotherapy and the treatment of depression in patients with severe traumatic brain injury: a controlled, prospective study","volume":"57","author":"Wroblewski","year":"1996","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.rehab.2015.10.003_bib0355","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1600-0447.1992.tb01472.x","article-title":"Treatment resistance of depression after head injury: a preliminary study of amitriptyline response","volume":"85","author":"Dinan","year":"1992","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.rehab.2015.10.003_bib0360","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/026990598122908","article-title":"Prevalence of apathy following head injury","volume":"12","author":"Kant","year":"1998","journal-title":"Brain inj"},{"key":"10.1016\/j.rehab.2015.10.003_bib0365","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1080\/026990599121197","article-title":"Paroxetine versus citalopram treatment of pathological crying after brain injury","volume":"13","author":"Muller","year":"1999","journal-title":"Brain Inj"},{"key":"10.1016\/j.rehab.2015.10.003_bib0370","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1212\/WNL.54.4.895","article-title":"Neuropsychological effects of valproate in traumatic brain injury: a randomized trial","volume":"22","author":"Dikmen","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.rehab.2015.10.003_bib0375","first-page":"219","article-title":"Neurobehavioral effects of phenytoin, carbamazepine and valproic acid: implications for use in traumatic brain injury","volume":"72","author":"Massagli","year":"1991","journal-title":"Arch Phys Med Rehab"},{"key":"10.1016\/j.rehab.2015.10.003_bib0380","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1001\/archneur.1994.00540190029012","article-title":"Neurobehavioral effects of phenytoin and carbamazepine in patients recovering from brain trauma: a comparative study","volume":"51","author":"Smith","year":"1994","journal-title":"Arch Neurol"},{"key":"10.1016\/j.rehab.2015.10.003_bib0385","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1176\/jnp.12.3.395","article-title":"Agitated symptom response to divalproex following acute brain injury","volume":"12","author":"Chatham Showalter","year":"2000","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.rehab.2015.10.003_bib0390","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1176\/jnp.14.2.202","article-title":"Divalproex in the management of neuropsychiatric complications of remote acquired brain injury","volume":"14","author":"Kim","year":"2002","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.rehab.2015.10.003_bib0395","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/026990597123791","article-title":"Effectiveness of valproic acid on destructive and aggressive behaviours in patients with acquired brain injury","volume":"11","author":"Wroblewski","year":"1997","journal-title":"Brain Inj"},{"key":"10.1016\/j.rehab.2015.10.003_bib0400","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1080\/026990599121188","article-title":"Carbamazepine in agitation and aggressive behaviour following severe closed head injury: results of an open trial","volume":"13","author":"Azouvi","year":"1999","journal-title":"Brain Inj"},{"key":"10.1016\/j.rehab.2015.10.003_bib0405","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1176\/jnp.8.1.96","article-title":"Carbamazepine for combativeness in acute traumatic brain injury","volume":"8","author":"Chatham-Showalter","year":"1996","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.rehab.2015.10.003_bib0410","first-page":"269","article-title":"The Kluver-Bucy syndrome","volume":"41","author":"G\u00f3sc\u00ednski","year":"1997","journal-title":"J Neurosurg Sci"},{"key":"10.1016\/j.rehab.2015.10.003_bib0415","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.yebeh.2004.07.004","article-title":"What is the evidence that oxcarbazepine and carbamazepine are distinctly different antiepileptic drugs?","volume":"5","author":"Schmidt","year":"2004","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.rehab.2015.10.003_bib0420","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/01.jcp.0000186739.22395.6b","article-title":"Oxcarbazepine in patients with impulsive aggression: a double-blind placebo-controlled trial","volume":"6","author":"Mattes","year":"2005","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.rehab.2015.10.003_bib0425","first-page":"234","article-title":"Medications for aggressiveness in prison: focus on oxcarbazepine","volume":"40","author":"Mattes","year":"2012","journal-title":"J Am Acad Psychiatry Law"},{"key":"10.1016\/j.rehab.2015.10.003_bib0430","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1080\/0269905031000110445","article-title":"Beneficial behavioural effects of lamotrigine in traumatic brain injury","volume":"17","author":"Pachet","year":"2003","journal-title":"Brain Inj"},{"key":"10.1016\/j.rehab.2015.10.003_bib0435","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.yebeh.2006.01.017","article-title":"Du rire aux larmes: pathological laughing and crying in patients with traumatic brain injury and treatment with lamotrigine","volume":"8","author":"Chahine","year":"2006","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.rehab.2015.10.003_bib0440","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1080\/bij.11.7.537.540","article-title":"Pychomotor agitation following Gabapentin use in brain injury","volume":"11","author":"Childers","year":"1997","journal-title":"Brain Inj"},{"key":"10.1016\/j.rehab.2015.10.003_bib0445","doi-asserted-by":"crossref","first-page":"310","DOI":"10.4088\/JCP.v69n0218","article-title":"Levetiracetam in patients with impulsive aggression: a double-blind, placebo-controlled trial","volume":"69","author":"Mattes","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.rehab.2015.10.003_bib0450","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2165\/00023210-200418010-00004","article-title":"Cognitive effects of long-term benzodiazepine use: a meta-analysis","volume":"18","author":"Barker","year":"2004","journal-title":"CNS Drugs"},{"key":"10.1016\/j.rehab.2015.10.003_bib0455","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/WCO.0b013e32831897a3","article-title":"Pharmacotherapy in restorative neurology","volume":"21","author":"Liepert","year":"2008","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.rehab.2015.10.003_bib0460","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1365-2710.2005.00628.x","article-title":"Amantadine for traumatic brain injury: does it improve cognition and reduce agitation?","volume":"30","author":"Leone","year":"2005","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.rehab.2015.10.003_bib0465","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1176\/jnp.9.2.222","article-title":"Effect of amantadine hydrochloride on symptoms of frontal lobe dysfunction in brain injury: case studies and review","volume":"9","author":"Kraus","year":"1997","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.rehab.2015.10.003_bib0470","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1080\/026990597123430","article-title":"The combined use of amantadine and l-dopa\/carbidopa in the treatment of chronic brain injury","volume":"11","author":"Kraus","year":"1997","journal-title":"Brain Inj"},{"key":"10.1016\/j.rehab.2015.10.003_bib0475","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1080\/02699050400025059","article-title":"Effects of the dopaminergic agent and NMDA receptor antagonist amantadine on cognitive function, cerebral glucose metabolism and D2 receptor availability in chronic traumatic brain injury: a study using positron emission tomography (PET)","volume":"19","author":"Kraus","year":"2005","journal-title":"Brain Inj"},{"key":"10.1016\/j.rehab.2015.10.003_bib0480","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3109\/02699058809150901","article-title":"Amantadine for the agitated head-injury patient","volume":"2","author":"Chandler","year":"1988","journal-title":"Brain Inj"},{"key":"10.1016\/j.rehab.2015.10.003_bib0485","doi-asserted-by":"crossref","first-page":"709","DOI":"10.3109\/02699059409151025","article-title":"Clinical use of amantadine in brain injury rehabilitation","volume":"8","author":"Nickels","year":"1994","journal-title":"Brain Inj"},{"key":"10.1016\/j.rehab.2015.10.003_bib0490","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1080\/026990599121061","article-title":"Cognitive and behavioural efficacy of amantadine in acute traumatic brain injury: an initial double-blind placebo-controlled study","volume":"13","author":"Schneider","year":"1999","journal-title":"Brain Inj"},{"key":"10.1016\/j.rehab.2015.10.003_bib0495","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/00001199-200208000-00004","article-title":"Amantadine to improve neurorecovery in traumatic brain injury-associated diffuse axonal injury: a pilot double-blind randomized trial","volume":"17","author":"Meythaler","year":"2002","journal-title":"J Head Trauma Rehabil"},{"key":"10.1016\/j.rehab.2015.10.003_bib0500","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3109\/02699059509004571","article-title":"N of 1 study: amantadine for the amotivational syndrome in a patient with traumatic brain injury","volume":"9","author":"Van Reekum","year":"1995","journal-title":"Brain Inj"},{"key":"10.1016\/j.rehab.2015.10.003_bib0505","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1176\/jnp.7.1.23","article-title":"Apathy: a treatable syndrome","volume":"7","author":"Marin","year":"1995","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.rehab.2015.10.003_bib0510","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/PHM.0b013e31811473b3","article-title":"Amantadine for adynamic speech: possible benefit for aphasia?","volume":"86","author":"Barrett","year":"2007","journal-title":"Am J Phys Med Rehabil"},{"key":"10.1016\/j.rehab.2015.10.003_bib0515","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1080\/026990598122386","article-title":"Amantadine: a potential treatment for the minimally conscious state","volume":"12","author":"Zafonte","year":"1998","journal-title":"Brain Inj"},{"key":"10.1016\/j.rehab.2015.10.003_bib0520","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1017\/S0317167100016826","article-title":"Review of awakening agents","volume":"32","author":"DeMarchi","year":"2005","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.rehab.2015.10.003_bib0525","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/00001199-200102000-00014","article-title":"Possible applications for dopaminergic agents following traumatic brain injury: part 2","volume":"16","author":"Zafonte","year":"2001","journal-title":"J Head Trauma Rehabil"},{"key":"10.1016\/j.rehab.2015.10.003_bib0530","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/00002826-199002000-00009","article-title":"Effects of long-term amantadine treatment on clinical symptoms and EEG of a patient in a vegetative state","volume":"13","author":"Horiguchi","year":"1990","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.rehab.2015.10.003_bib0535","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/026990599121908","article-title":"Effects of dopaminergic combination therapy for frontal lobe dysfunction in traumatic brain injury rehabilitation","volume":"13","author":"Karli","year":"1999","journal-title":"Brain Inj"},{"key":"10.1016\/j.rehab.2015.10.003_bib0540","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1080\/026990599121269","article-title":"Treatment with amantadine potentiated motor learning in a patient with traumatic brain injury of 15 years\u2019 duration","volume":"13","author":"Shiller","year":"1999","journal-title":"Brain Inj"},{"key":"10.1016\/j.rehab.2015.10.003_bib0545","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1345\/aph.1K284","article-title":"Amantadine enhancement of arousal and cognition after traumatic brain injury","volume":"42","author":"Sawyer","year":"2008","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.rehab.2015.10.003_bib0550","doi-asserted-by":"crossref","first-page":"722","DOI":"10.3109\/02699051003692134","article-title":"Acute management of acquired brain injury Part III: an evidence-based review of interventions used to promote arousal from coma","volume":"24","author":"Meyer","year":"2010","journal-title":"Brain Inj"},{"key":"10.1016\/j.rehab.2015.10.003_bib0555","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/neu.2011.1812","article-title":"Efficacy and safety of dopamine agonists in traumatic brain injury: a systematic review of randomized controlled trials","volume":"29","author":"Frenette","year":"2012","journal-title":"J Neurotrauma"},{"key":"10.1016\/j.rehab.2015.10.003_bib0560","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJMoa1102609","article-title":"Placebo controlled trial of amantadine for severe traumatic brain injury","volume":"366","author":"Giacino","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rehab.2015.10.003_bib0565","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1212\/WNL.43.10.2155","article-title":"Amantadine withdrawal and neuroleptic malignant syndrome","volume":"43","author":"Weller","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.rehab.2015.10.003_bib0570","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1080\/02699050902970745","article-title":"Effect of amantadine on the sleep-wake cycle of an inpatient with brain injury","volume":"23","author":"Adawi","year":"2009","journal-title":"Brain Inj"},{"key":"10.1016\/j.rehab.2015.10.003_bib0575","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/01.HTR.0000438116.56228.de","article-title":"Effectiveness of amantadine hydrochloride in the reduction of chronic traumatic brain injury irritability and aggression","volume":"29","author":"Hammond","year":"2014","journal-title":"J Head Trauma Rehabil"},{"key":"10.1016\/j.rehab.2015.10.003_bib0580","first-page":"31","article-title":"Amantadine effect on perceptions of irritability after traumatic brain injury: results of the amantadine irritability multisite study","author":"Hammond","year":"2015","journal-title":"J Neurotrauma"},{"key":"10.1016\/j.rehab.2015.10.003_bib0585","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/0269905031000110463","article-title":"The role of pharmacotherapy in the management of behaviour disorders in traumatic brain injury patients","volume":"18","author":"Deb","year":"2004","journal-title":"Brain Inj"},{"key":"10.1016\/j.rehab.2015.10.003_bib0590","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/00004714-199108000-00027","article-title":"Buspirone for the behavior problems of patients with organic brain disorders","volume":"11","author":"Gualtieri","year":"1991","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.rehab.2015.10.003_bib0595","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/00004714-199404000-00007","article-title":"Buspirone's efficacy in organic-induced aggression","volume":"14","author":"Stanislav","year":"1994","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.rehab.2015.10.003_bib0600","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1176\/jnp.10.1.113","article-title":"Buspirone and brain injury","volume":"10","author":"Holzer","year":"1998","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.rehab.2015.10.003_bib0605","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/00004714-199210000-00016","article-title":"Low-dose buspirone to treat agitation and maladaptive behavior in brain-injured patients: two case reports","volume":"12","author":"Ratey","year":"1992","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.rehab.2015.10.003_bib0610","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1080\/026990598122269","article-title":"Medroxyprogesterone in the treatment of aggressive hypersexual behavior in traumatic brain injury","volume":"12","author":"Britton","year":"1998","journal-title":"Brain Inj"},{"key":"10.1016\/j.rehab.2015.10.003_bib0615","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1176\/ajp.150.10.1564b","article-title":"Estrogen for refractory aggression after traumatic brain injury","volume":"150","author":"Arnold","year":"1993","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.rehab.2015.10.003_bib0620","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3917\/inpsy.8805.0375","article-title":"Prise en charge pharmacologique des troubles neurocomportementaux apr\u00e8s traumatisme cr\u00e2nien\u00a0: revue bibliographique, donn\u00e9es pratiques actuelles","volume":"88","author":"Plantier","year":"2012","journal-title":"L\u2019information psychiatrique"},{"key":"10.1016\/j.rehab.2015.10.003_bib0625","first-page":"46","article-title":"La prescription hors AMM","volume":"6","author":"Paoletti","year":"2003","journal-title":"Neurologies"}],"container-title":["Annals of Physical and Rehabilitation Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877065715005540?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877065715005540?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,17]],"date-time":"2022-07-17T15:07:23Z","timestamp":1658070443000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877065715005540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":125,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S1877065715005540"],"URL":"https:\/\/doi.org\/10.1016\/j.rehab.2015.10.003","relation":{},"ISSN":["1877-0657"],"issn-type":[{"value":"1877-0657","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drugs for behavior disorders after traumatic brain injury: Systematic review and expert consensus leading to French recommendations for good practice","name":"articletitle","label":"Article Title"},{"value":"Annals of Physical and Rehabilitation Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rehab.2015.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}